286
We report a patient with chronic renal failure and ischemic heart disease who developed clinically significant methemoglobinemia after an axillary block with bupivacaine and additional injection of lidocaine in the operative field.
 a patient with chronic renal failure and ischemic heart disease: Subject; clinically significant methemoglobinemia: Effect; an axillary block with bupivacaine and additional injection of lidocaine in the operative field: Treatment; chronic renal failure and ischemic heart disease: Treatment.Disorder; bupivacaine: Treatment.Drug; lidocaine: Treatment.Drug; injection: Treatment.Route; bupivacaine: Combination.Drug; lidocaine: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a patient with chronic renal failure and ischemic heart disease: Subject; clinically significant methemoglobinemia: Effect; an axillary block with bupivacaine and additional injection of lidocaine in the operative field: Treatment; chronic renal failure and ischemic heart disease: Treatment.Disorder; bupivacaine: Treatment.Drug; lidocaine: Treatment.Drug; injection: Treatment.Route; bupivacaine: Combination.Drug; lidocaine: Combination.Drug